Thyrogen 투여 후 측정된 Thyroglobulin 농도변화

The Variation of Serum Thyroglobulin Measured after Thyrogen Administration

  • Kim, Ji-Na (Department of Nuclear Medicine, National Cancer Center) ;
  • An, Jae-seok (Department of Nuclear Medicine, National Cancer Center) ;
  • Won, Woo-Jae (Department of Nuclear Medicine, National Cancer Center)
  • 투고 : 2018.04.14
  • 심사 : 2018.04.30
  • 발행 : 2018.05.19

초록

Purpose Assessment of Serum Thyroglobulin (sTg) value in total thyroidectomy patients having an ablation dose of radioactive iodine indicates remaining cancer or metastasis. Especially, sTg in patients on withdrawal thyroxine or thyrogen administration for radioiodine ablation is an important indicator to determine the direction of further treatment and prognosis. Current guidelines suggest measurement of sTg is performed at 72 hours after the last injection of thyrogen. and assumes that sTg reaches maximum serum levels at that time. The purpose of this study is to evaluate the variation of sTg measured after thyrogen administration. Materials and Methods We compared with sTg performed at 24hours(D0) and 72hours(D2) after the last injection of thyrogen. We reviewed D0 and D2 from 276 patients were divided them into three groups according to ablation dose of radioactive iodine, 5mCi(A group), 30~80mCi(B group) and 100~200mCi(C group). We used T-test for comparison between D0 and D2. sTg was measured in serum using immunoradiometric assay (Tg-plus RIA; BRAHMS, Berlin, Germany). Results There is no critical variation between D0 and D2 in A group(n=100)(P=0.32), The case of increase(D2>D0) is 45, no change(D2=D0) is 23, decrease(D2D0 is 91, D2=D0 is 28, D2D0 is 19, D2=D0 is 2. The biggest increase is 143.6 ng/mL from 98.4 to 242. Conclusion There was a significant difference in the group over 30mCi. and the case of D2>D0 is 45%, 58.7%, 90.5% for each group. therefore, D2 increased as the dose of radioactive iodine increased. Furthermore, the most sTg values of D0 and D2 are variation under 2.0 ng/mL, so reproducibility as well as sensitivity of sTg will be important at values below 2ng/mL.

키워드

참고문헌

  1. Goldman et al.,Influence of triiodothyronine withdrawal time on I-131 uptake post thyroidectomy for thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 1980; 50: 734-739. https://doi.org/10.1210/jcem-50-4-734
  2. SANOFI GENZYME Web. Available at: https://www.thyrogen.com/patients/About-Thy rogen/What-is-Thyrogen.aspx February 2018.
  3. Verburg FA, de Keizer B, de Klerk JM, Lenties EG, Lips CJ, van lsselt JW. Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection. Nuklearmedizin. 2009;48(1): 26-9. https://doi.org/10.3413/nukmed-0189
  4. Pellegriti G et al. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clinical endocrinology 2003;58: 559-561.
  5. Robbins R J et al. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? Journal of Clinical Endocrinology and Metabolism, 2002; 87: 3242-3247. https://doi.org/10.1210/jcem.87.7.8702